In this study, a retrospective analysis was conducted to investigate the incidence of ANA and APS-associated autoantibodies in psoriasis patients following treatment with TNF, IL-17, and IL-23 inhibitors. Here, IL17A is linked to autoimmune polyendocrinopathy.